On August 1st, the Senate voted against the Tax Relief for American Families and Workers Act of 2024 (H.R. 7024) by a vote of 48-44. The bill, which previously passed the House overwhelmingly 357 to 70, would have restored crucial research and experimentation (“R&E”) deductions for taxpayers, as well as other tax relief for businesses. Specifically, if passed, the new provisions would have allowed taxpayers to immediately deduct R&E costs, delaying the capitalization requirement for domestic R&E expenses until December 31, 2025. However, as a result of the Senate’s vote, taxpayers will continue to be required to capitalize and amortize IRC § 174 R&E costs for tax years ending after December 31, 2021 over five or fifteen years, depending on whether research is domestic or foreign.
Read More